Requests that the FDA declare that the FDA determine and declare that Promethazine Hydrochloride Suppositories USP, 6.25 mg is suitable for submission in an Abbreviated New Drug Application (ANDA).
🏛 Food and Drug Administration (FDA)FDA-2026-P-8562
Documents
3
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
- Supporting & Related Material· Aug 4, 2026